James Carroll has led the Office of National Drug Control Policy in an acting capacity since February. The Senate also confirmed Kelvin Droegemeier to head up the White House’s Office of Science and Technology, giving the office a director for the first time since President Donald Trump's inauguration.

from Kaiser Health News http://bit.ly/2Asq3Jg

0 comments:

Post a Comment

Popular Posts